Skip to main content
TSNDF
OTC Industrial Applications And Services

TerrAscend Reports Preliminary Q1 2026 Results: Revenue Growth, Strong Margins, and Consistent Positive Cash Flow

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Positive
Importance info
7
Price
$0.93
Mkt Cap
$245.164M
52W Low
$0.227
52W High
$1.45
52W Position info
309% above low
Off High info
36% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

TSNDF has more than doubled off its 52-week low of $0.227.

Summary

TerrAscend announced preliminary Q1 2026 results showing year-over-year revenue growth from continuing operations, improved gross profit margins, and its 15th consecutive quarter of positive cash flow from operations.


Key Events · Earnings and Guidance · TSNDF

  • Preliminary Q1 2026 Financial Results

    TerrAscend reported preliminary net revenue of $65.5 million for Q1 2026, marking year-over-year growth from continuing operations compared to $64.3 million in Q1 2025.

  • Improved Gross Profit Margin

    The company achieved a preliminary gross profit margin of 52.8% in Q1 2026, an increase from 52.1% in the prior quarter (Q4 2025).

  • Consistent Positive Cash Flow

    TerrAscend generated positive cash flow from operations for the 15th consecutive quarter, highlighting strong operational efficiency and financial stability.

  • Industry Regulatory Tailwinds

    The Executive Chairman noted the positive operational momentum combined with the recently completed rescheduling of medical cannabis, anticipating further progress in the regulatory landscape.


Analysis · TSNDF · Industrial Applications And Services

TerrAscend's preliminary Q1 2026 results indicate a positive shift in operational momentum, especially following a challenging fiscal year 2025 which saw a significant net loss. The return to year-over-year revenue growth from continuing operations, coupled with an improved gross profit margin quarter-over-quarter, suggests effective cost management and market penetration. Crucially, the company's achievement of 15 consecutive quarters of positive cash flow from operations demonstrates strong underlying financial health and sustainability, providing a stable foundation amidst broader industry developments like the rescheduling of medical cannabis. Investors should monitor the full earnings report for confirmation of these preliminary figures and further details on the impact of regulatory changes.

At the time of this filing, TSNDF was trading at $0.93 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $245.2M. The 52-week trading range was $0.23 to $1.45. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TSNDF - Latest Insights

TSNDF
Jul 06, 2026, 9:14 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.630
Real-time Price: $0.5422 info
Change: -$0.0878 (-14%) info
Market Cap: $202.06M info
TSNDF
Jun 25, 2026, 5:06 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.6814
Real-time Price: $0.5422 info
Change: -$0.1392 (-20%) info
Market Cap: $202.06M info
TSNDF
Jun 25, 2026, 4:58 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.6814
Real-time Price: $0.5422 info
Change: -$0.1392 (-20%) info
Market Cap: $202.06M info
TSNDF
May 07, 2026, 7:35 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.7569
Real-time Price: $0.5422 info
Change: -$0.2147 (-28%) info
Market Cap: $202.06M info
TSNDF
Apr 16, 2026, 4:36 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.6619
Real-time Price: $0.5422 info
Change: -$0.1197 (-18%) info
Market Cap: $202.06M info